STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABT
  4. [8-K] Abbott Laboratories Reports Material Event

[8-K] Abbott Laboratories Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ABT logo
Abbott Labs

NYSE:ABT

ABT Rankings

#57 Ranked by Market Cap
#1432 Ranked by Dividends

ABT Latest News

Jul 17, 2025
Abbott Reports Second-Quarter 2025 Results
Jun 26, 2025
Abbott Hosts Conference Call for Second-Quarter Earnings
Jun 20, 2025
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier
Jun 13, 2025
Abbott Declares 406th Consecutive Quarterly Dividend
May 27, 2025
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

ABT Latest SEC Filings

Jul 1, 2025
[Form 4] Abbott Laboratories Insider Trading Activity
Jul 1, 2025
[Form 4] Abbott Laboratories Insider Trading Activity
Jul 1, 2025
[Form 4] Abbott Laboratories Insider Trading Activity
Jul 1, 2025
[Form 4] Abbott Laboratories Insider Trading Activity
Jul 1, 2025
[Form 4] Abbott Laboratories Insider Trading Activity

ABT Stock Data

231.78B
1.73B
0.54%
79.44%
1.32%
Medical Devices
Pharmaceutical Preparations
Link
United States
ABBOTT PARK